Target type: biologicalprocess
The directed movement of azoles, heterocyclic compounds found in many biologically important substances, across a lipid bilayer, across a membrane. [GOC:go_curators, ISBN:3527307206, Wikipedia:Azole]
Azole transmembrane transport is a complex process that involves the movement of azole antifungal drugs across cell membranes. Azoles are a class of antifungal drugs that inhibit the synthesis of ergosterol, an essential component of fungal cell membranes. This inhibition disrupts the integrity of the fungal cell membrane, leading to cell death.
The transmembrane transport of azoles is mediated by various mechanisms, including passive diffusion, facilitated diffusion, and active transport.
**Passive diffusion** is the movement of azoles across the cell membrane down their concentration gradient, meaning from an area of high concentration to an area of low concentration. This process does not require energy and is dependent on the lipophilicity of the azole drug. More lipophilic azoles, such as ketoconazole, are more readily transported across the cell membrane by passive diffusion.
**Facilitated diffusion** involves the interaction of azoles with specific membrane proteins, called transporters, to facilitate their movement across the cell membrane. These transporters can increase the rate of azole transport by providing a pathway for the drug to move across the membrane more readily.
**Active transport** is the movement of azoles against their concentration gradient, requiring energy. This process involves the use of specific membrane proteins, called pumps, that actively transport azoles out of the cell. Examples of pumps involved in azole efflux include the ATP-binding cassette (ABC) transporters, such as MDR1 (P-glycoprotein).
The transmembrane transport of azoles is influenced by several factors, including the physicochemical properties of the azole drug, the characteristics of the fungal cell membrane, and the presence of efflux pumps.
**Physicochemical properties:**
* **Lipophilicity:** More lipophilic azoles are more readily transported across the cell membrane by passive diffusion.
* **Size and shape:** The size and shape of the azole molecule can influence its ability to interact with transporters and pass through the cell membrane.
* **Charge:** The charge of the azole molecule can influence its interaction with the cell membrane.
**Fungal cell membrane characteristics:**
* **Ergosterol content:** The amount of ergosterol in the fungal cell membrane can affect the permeability of the membrane to azoles.
* **Lipid composition:** The composition of lipids in the fungal cell membrane can influence the transport of azoles across the membrane.
**Efflux pumps:**
* **Expression levels:** The expression levels of efflux pumps can determine the rate of azole efflux from the cell.
* **Substrate specificity:** Efflux pumps have different substrate specificities, meaning they can transport different azole drugs with varying efficiencies.
The transmembrane transport of azoles is a crucial factor in their antifungal activity. Understanding this process can help to improve the efficacy of azole antifungal drugs and minimize the risk of drug resistance.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sodium/nucleoside cotransporter 2 | A sodium/nucleoside cotransporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43868] | Homo sapiens (human) |
Sodium/nucleoside cotransporter 1 | A sodium/nucleoside cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00337] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
floxuridine | floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. | nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent |
uridine | uridines | drug metabolite; fundamental metabolite; human metabolite | |
phlorhizin | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite | |
adenosine | quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
tecadenoson | tecadenoson: an A1 adenosine receptor agonist | ||
7,8,3'-trihydroxyflavone | 7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo |